Skip to content

    TAKEDA PHARMACEUTICAL CO LTD

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25
    AssetsCash & Equivalents$2.77B$6.34B$5.87B$8.72B$6.98B$4.01B$3.03B$2.58B
    Short-Term Investments
    Total Current Assets$10.13B$27.03B$22.74B$24.50B$21.29B$18.01B$16.91B$16.87B
    Net PP&E$5.04B$12.03B$12.77B$13.13B$12.99B$12.70B
    Goodwill$9.66B$38.29B$36.96B$36.43B$36.19B$35.98B$35.76B$35.62B
    Intangibles$9.52B$42.90B$38.42B$35.30B$31.35B$32.07B$28.26B$24.30B
    Total Assets$38.56B$124.55B$118.08B$116.60B$108.19B$104.82B$99.87B$95.32B
    LiabilitiesTotal Current Liabilities$6.93B$23.05B$20.04B$16.01B$17.62B$18.64B$15.29B$16.77B
    Short-Term Debt
    Long-Term Debt$9.26B$43.04B$41.50B$41.66B$34.00B$30.36B$29.59B$26.53B
    Long-Term Leases
    Total Liabilities$19.62B$77.72B$74.54B$69.85B$61.53B$57.10B$51.79B$48.92B
    EquityCommon Stock & APIC
    Retained Earnings
    Total Equity$18.94B$46.83B$43.54B$46.75B$46.68B$47.72B$48.08B$46.40B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25
    ActivitiesCash from Operating$3.55B$2.97B$6.17B$9.13B$9.22B$7.34B$4.74B$7.07B
    Cash from Investing-$876.48M-$25.61B$2.69B$3.55B-$1.63B-$4.56B-$3.07B-$2.46B
    Cash from Financing-$3.06B$26.60B-$9.26B-$9.83B-$8.79B-$5.33B-$2.34B-$5.03B
    SummaryCapital Expenditure-$629.18M-$701.42M-$1.17B-$1.00B-$1.01B-$1.06B-$1.16B-$1.34B
    Free Cash Flow$2.92B$2.26B$5.00B$8.12B$8.21B$6.28B$3.58B$5.73B
    FCF Margin17.6%12.0%16.5%28.1%28.0%20.8%12.7%18.7%